Dynavax Technologies Competitors and Similar CompaniesClear all
Dynavax Technologies's competitors and similar companies include Livzon Pharmaceutical Group, Chiesi Group, YiChang HEC ChangJiang Pharmaceutical and UCB.
 Dynavax Technologies Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1996 | Founding Date 1985 | Founding Date 1935 | Founding Date 2001 | Founding Date 1928 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ Düsseldorf, DE Berkeley, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 24946% increase | Employees 9,067 | Employees 5,8541% increase | Employees 4,595 | Employees 9,052 |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $277.2m (FY, 2024) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥3.7b (FY, 2024) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $27.3m (FY, 2024) | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income ¥482.7m (FY, 2024) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyYiChang HEC ChangJiang Pharmaceutical
HQ
Employees
4,595
YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company